Global Tuberculosis Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked.
The Global Tuberculosis Drugs Market Size was estimated at USD 1222.71 million in 2023 and is projected to reach USD 1601.46 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
This report provides a deep insight into the global Tuberculosis Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Drugs market in any manner.
Global Tuberculosis Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Lupin Laboratories Ltd
AstraZeneca Plc
Cadila Pharmaceuticals
Novartis AG
Alkem Laboratories Ltd
Cipla Ltd
Otsuka Pharmaceutical
Sanofi
Abbott
ANI Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Macleods Pharmaceuticals Ltd.
Johnson & Johnson
FRESENIUS SE & Co. KGaA (Fresenius Kabi)
Eli Lilly and Company
Viatris Inc. (Mylan N.V.)
Sun Pharmaceutical Industries Ltd.
Market Segmentation (by Type)
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
Market Segmentation (by Application)
Hospital
Private Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked.
The Global Tuberculosis Drugs Market Size was estimated at USD 1222.71 million in 2023 and is projected to reach USD 1601.46 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
This report provides a deep insight into the global Tuberculosis Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Drugs market in any manner.
Global Tuberculosis Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Lupin Laboratories Ltd
AstraZeneca Plc
Cadila Pharmaceuticals
Novartis AG
Alkem Laboratories Ltd
Cipla Ltd
Otsuka Pharmaceutical
Sanofi
Abbott
ANI Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Macleods Pharmaceuticals Ltd.
Johnson & Johnson
FRESENIUS SE & Co. KGaA (Fresenius Kabi)
Eli Lilly and Company
Viatris Inc. (Mylan N.V.)
Sun Pharmaceutical Industries Ltd.
Market Segmentation (by Type)
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
Market Segmentation (by Application)
Hospital
Private Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tuberculosis Drugs Market
- Overview of the regional outlook of the Tuberculosis Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tuberculosis Drugs
1.2 Key Market Segments
1.2.1 Tuberculosis Drugs Segment by Type
1.2.2 Tuberculosis Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tuberculosis Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tuberculosis Drugs Sales by Manufacturers (2019-2024)
3.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tuberculosis Drugs Sales Sites, Area Served, Product Type
3.6 Tuberculosis Drugs Market Competitive Situation and Trends
3.6.1 Tuberculosis Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Drugs Sales Market Share by Type (2019-2024)
6.3 Global Tuberculosis Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Tuberculosis Drugs Price by Type (2019-2024)
7 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Drugs Market Sales by Application (2019-2024)
7.3 Global Tuberculosis Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
8 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Tuberculosis Drugs Sales by Region
8.1.1 Global Tuberculosis Drugs Sales by Region
8.1.2 Global Tuberculosis Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Tuberculosis Drugs Basic Information
9.1.2 Pfizer Inc Tuberculosis Drugs Product Overview
9.1.3 Pfizer Inc Tuberculosis Drugs Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Tuberculosis Drugs SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Lupin Laboratories Ltd
9.2.1 Lupin Laboratories Ltd Tuberculosis Drugs Basic Information
9.2.2 Lupin Laboratories Ltd Tuberculosis Drugs Product Overview
9.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Product Market Performance
9.2.4 Lupin Laboratories Ltd Business Overview
9.2.5 Lupin Laboratories Ltd Tuberculosis Drugs SWOT Analysis
9.2.6 Lupin Laboratories Ltd Recent Developments
9.3 AstraZeneca Plc
9.3.1 AstraZeneca Plc Tuberculosis Drugs Basic Information
9.3.2 AstraZeneca Plc Tuberculosis Drugs Product Overview
9.3.3 AstraZeneca Plc Tuberculosis Drugs Product Market Performance
9.3.4 AstraZeneca Plc Tuberculosis Drugs SWOT Analysis
9.3.5 AstraZeneca Plc Business Overview
9.3.6 AstraZeneca Plc Recent Developments
9.4 Cadila Pharmaceuticals
9.4.1 Cadila Pharmaceuticals Tuberculosis Drugs Basic Information
9.4.2 Cadila Pharmaceuticals Tuberculosis Drugs Product Overview
9.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Product Market Performance
9.4.4 Cadila Pharmaceuticals Business Overview
9.4.5 Cadila Pharmaceuticals Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Tuberculosis Drugs Basic Information
9.5.2 Novartis AG Tuberculosis Drugs Product Overview
9.5.3 Novartis AG Tuberculosis Drugs Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 Alkem Laboratories Ltd
9.6.1 Alkem Laboratories Ltd Tuberculosis Drugs Basic Information
9.6.2 Alkem Laboratories Ltd Tuberculosis Drugs Product Overview
9.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Product Market Performance
9.6.4 Alkem Laboratories Ltd Business Overview
9.6.5 Alkem Laboratories Ltd Recent Developments
9.7 Cipla Ltd
9.7.1 Cipla Ltd Tuberculosis Drugs Basic Information
9.7.2 Cipla Ltd Tuberculosis Drugs Product Overview
9.7.3 Cipla Ltd Tuberculosis Drugs Product Market Performance
9.7.4 Cipla Ltd Business Overview
9.7.5 Cipla Ltd Recent Developments
9.8 Otsuka Pharmaceutical
9.8.1 Otsuka Pharmaceutical Tuberculosis Drugs Basic Information
9.8.2 Otsuka Pharmaceutical Tuberculosis Drugs Product Overview
9.8.3 Otsuka Pharmaceutical Tuberculosis Drugs Product Market Performance
9.8.4 Otsuka Pharmaceutical Business Overview
9.8.5 Otsuka Pharmaceutical Recent Developments
9.9 Sanofi
9.9.1 Sanofi Tuberculosis Drugs Basic Information
9.9.2 Sanofi Tuberculosis Drugs Product Overview
9.9.3 Sanofi Tuberculosis Drugs Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
9.10 Abbott
9.10.1 Abbott Tuberculosis Drugs Basic Information
9.10.2 Abbott Tuberculosis Drugs Product Overview
9.10.3 Abbott Tuberculosis Drugs Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
9.11 ANI Pharmaceuticals, Inc
9.11.1 ANI Pharmaceuticals, Inc Tuberculosis Drugs Basic Information
9.11.2 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Overview
9.11.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Market Performance
9.11.4 ANI Pharmaceuticals, Inc Business Overview
9.11.5 ANI Pharmaceuticals, Inc Recent Developments
9.12 Teva Pharmaceutical Industries Ltd
9.12.1 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Basic Information
9.12.2 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Overview
9.12.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Market Performance
9.12.4 Teva Pharmaceutical Industries Ltd Business Overview
9.12.5 Teva Pharmaceutical Industries Ltd Recent Developments
9.13 Macleods Pharmaceuticals Ltd.
9.13.1 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Basic Information
9.13.2 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Overview
9.13.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Market Performance
9.13.4 Macleods Pharmaceuticals Ltd. Business Overview
9.13.5 Macleods Pharmaceuticals Ltd. Recent Developments
9.14 Johnson and Johnson
9.14.1 Johnson and Johnson Tuberculosis Drugs Basic Information
9.14.2 Johnson and Johnson Tuberculosis Drugs Product Overview
9.14.3 Johnson and Johnson Tuberculosis Drugs Product Market Performance
9.14.4 Johnson and Johnson Business Overview
9.14.5 Johnson and Johnson Recent Developments
9.15 FRESENIUS SE and Co. KGaA (Fresenius Kabi)
9.15.1 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Basic Information
9.15.2 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Overview
9.15.3 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Market Performance
9.15.4 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Business Overview
9.15.5 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Recent Developments
9.16 Eli Lilly and Company
9.16.1 Eli Lilly and Company Tuberculosis Drugs Basic Information
9.16.2 Eli Lilly and Company Tuberculosis Drugs Product Overview
9.16.3 Eli Lilly and Company Tuberculosis Drugs Product Market Performance
9.16.4 Eli Lilly and Company Business Overview
9.16.5 Eli Lilly and Company Recent Developments
9.17 Viatris Inc. (Mylan N.V.)
9.17.1 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Basic Information
9.17.2 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Overview
9.17.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Market Performance
9.17.4 Viatris Inc. (Mylan N.V.) Business Overview
9.17.5 Viatris Inc. (Mylan N.V.) Recent Developments
9.18 Sun Pharmaceutical Industries Ltd.
9.18.1 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Basic Information
9.18.2 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Overview
9.18.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Market Performance
9.18.4 Sun Pharmaceutical Industries Ltd. Business Overview
9.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
10 TUBERCULOSIS DRUGS MARKET FORECAST BY REGION
10.1 Global Tuberculosis Drugs Market Size Forecast
10.2 Global Tuberculosis Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Drugs Market Size Forecast by Region
10.2.4 South America Tuberculosis Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tuberculosis Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tuberculosis Drugs by Type (2025-2030)
11.1.2 Global Tuberculosis Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tuberculosis Drugs by Type (2025-2030)
11.2 Global Tuberculosis Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Tuberculosis Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Tuberculosis Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tuberculosis Drugs
1.2 Key Market Segments
1.2.1 Tuberculosis Drugs Segment by Type
1.2.2 Tuberculosis Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tuberculosis Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tuberculosis Drugs Sales by Manufacturers (2019-2024)
3.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tuberculosis Drugs Sales Sites, Area Served, Product Type
3.6 Tuberculosis Drugs Market Competitive Situation and Trends
3.6.1 Tuberculosis Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Drugs Sales Market Share by Type (2019-2024)
6.3 Global Tuberculosis Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Tuberculosis Drugs Price by Type (2019-2024)
7 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Drugs Market Sales by Application (2019-2024)
7.3 Global Tuberculosis Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
8 TUBERCULOSIS DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Tuberculosis Drugs Sales by Region
8.1.1 Global Tuberculosis Drugs Sales by Region
8.1.2 Global Tuberculosis Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Tuberculosis Drugs Basic Information
9.1.2 Pfizer Inc Tuberculosis Drugs Product Overview
9.1.3 Pfizer Inc Tuberculosis Drugs Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Tuberculosis Drugs SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Lupin Laboratories Ltd
9.2.1 Lupin Laboratories Ltd Tuberculosis Drugs Basic Information
9.2.2 Lupin Laboratories Ltd Tuberculosis Drugs Product Overview
9.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Product Market Performance
9.2.4 Lupin Laboratories Ltd Business Overview
9.2.5 Lupin Laboratories Ltd Tuberculosis Drugs SWOT Analysis
9.2.6 Lupin Laboratories Ltd Recent Developments
9.3 AstraZeneca Plc
9.3.1 AstraZeneca Plc Tuberculosis Drugs Basic Information
9.3.2 AstraZeneca Plc Tuberculosis Drugs Product Overview
9.3.3 AstraZeneca Plc Tuberculosis Drugs Product Market Performance
9.3.4 AstraZeneca Plc Tuberculosis Drugs SWOT Analysis
9.3.5 AstraZeneca Plc Business Overview
9.3.6 AstraZeneca Plc Recent Developments
9.4 Cadila Pharmaceuticals
9.4.1 Cadila Pharmaceuticals Tuberculosis Drugs Basic Information
9.4.2 Cadila Pharmaceuticals Tuberculosis Drugs Product Overview
9.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Product Market Performance
9.4.4 Cadila Pharmaceuticals Business Overview
9.4.5 Cadila Pharmaceuticals Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Tuberculosis Drugs Basic Information
9.5.2 Novartis AG Tuberculosis Drugs Product Overview
9.5.3 Novartis AG Tuberculosis Drugs Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 Alkem Laboratories Ltd
9.6.1 Alkem Laboratories Ltd Tuberculosis Drugs Basic Information
9.6.2 Alkem Laboratories Ltd Tuberculosis Drugs Product Overview
9.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Product Market Performance
9.6.4 Alkem Laboratories Ltd Business Overview
9.6.5 Alkem Laboratories Ltd Recent Developments
9.7 Cipla Ltd
9.7.1 Cipla Ltd Tuberculosis Drugs Basic Information
9.7.2 Cipla Ltd Tuberculosis Drugs Product Overview
9.7.3 Cipla Ltd Tuberculosis Drugs Product Market Performance
9.7.4 Cipla Ltd Business Overview
9.7.5 Cipla Ltd Recent Developments
9.8 Otsuka Pharmaceutical
9.8.1 Otsuka Pharmaceutical Tuberculosis Drugs Basic Information
9.8.2 Otsuka Pharmaceutical Tuberculosis Drugs Product Overview
9.8.3 Otsuka Pharmaceutical Tuberculosis Drugs Product Market Performance
9.8.4 Otsuka Pharmaceutical Business Overview
9.8.5 Otsuka Pharmaceutical Recent Developments
9.9 Sanofi
9.9.1 Sanofi Tuberculosis Drugs Basic Information
9.9.2 Sanofi Tuberculosis Drugs Product Overview
9.9.3 Sanofi Tuberculosis Drugs Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
9.10 Abbott
9.10.1 Abbott Tuberculosis Drugs Basic Information
9.10.2 Abbott Tuberculosis Drugs Product Overview
9.10.3 Abbott Tuberculosis Drugs Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
9.11 ANI Pharmaceuticals, Inc
9.11.1 ANI Pharmaceuticals, Inc Tuberculosis Drugs Basic Information
9.11.2 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Overview
9.11.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Market Performance
9.11.4 ANI Pharmaceuticals, Inc Business Overview
9.11.5 ANI Pharmaceuticals, Inc Recent Developments
9.12 Teva Pharmaceutical Industries Ltd
9.12.1 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Basic Information
9.12.2 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Overview
9.12.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Market Performance
9.12.4 Teva Pharmaceutical Industries Ltd Business Overview
9.12.5 Teva Pharmaceutical Industries Ltd Recent Developments
9.13 Macleods Pharmaceuticals Ltd.
9.13.1 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Basic Information
9.13.2 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Overview
9.13.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Market Performance
9.13.4 Macleods Pharmaceuticals Ltd. Business Overview
9.13.5 Macleods Pharmaceuticals Ltd. Recent Developments
9.14 Johnson and Johnson
9.14.1 Johnson and Johnson Tuberculosis Drugs Basic Information
9.14.2 Johnson and Johnson Tuberculosis Drugs Product Overview
9.14.3 Johnson and Johnson Tuberculosis Drugs Product Market Performance
9.14.4 Johnson and Johnson Business Overview
9.14.5 Johnson and Johnson Recent Developments
9.15 FRESENIUS SE and Co. KGaA (Fresenius Kabi)
9.15.1 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Basic Information
9.15.2 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Overview
9.15.3 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Market Performance
9.15.4 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Business Overview
9.15.5 FRESENIUS SE and Co. KGaA (Fresenius Kabi) Recent Developments
9.16 Eli Lilly and Company
9.16.1 Eli Lilly and Company Tuberculosis Drugs Basic Information
9.16.2 Eli Lilly and Company Tuberculosis Drugs Product Overview
9.16.3 Eli Lilly and Company Tuberculosis Drugs Product Market Performance
9.16.4 Eli Lilly and Company Business Overview
9.16.5 Eli Lilly and Company Recent Developments
9.17 Viatris Inc. (Mylan N.V.)
9.17.1 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Basic Information
9.17.2 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Overview
9.17.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Market Performance
9.17.4 Viatris Inc. (Mylan N.V.) Business Overview
9.17.5 Viatris Inc. (Mylan N.V.) Recent Developments
9.18 Sun Pharmaceutical Industries Ltd.
9.18.1 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Basic Information
9.18.2 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Overview
9.18.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Market Performance
9.18.4 Sun Pharmaceutical Industries Ltd. Business Overview
9.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
10 TUBERCULOSIS DRUGS MARKET FORECAST BY REGION
10.1 Global Tuberculosis Drugs Market Size Forecast
10.2 Global Tuberculosis Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Drugs Market Size Forecast by Region
10.2.4 South America Tuberculosis Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tuberculosis Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tuberculosis Drugs by Type (2025-2030)
11.1.2 Global Tuberculosis Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tuberculosis Drugs by Type (2025-2030)
11.2 Global Tuberculosis Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Tuberculosis Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Tuberculosis Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Drugs Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tuberculosis Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2022)
Table 10. Global Market Tuberculosis Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tuberculosis Drugs Sales Sites and Area Served
Table 12. Manufacturers Tuberculosis Drugs Product Type
Table 13. Global Tuberculosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tuberculosis Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Drugs Market Challenges
Table 22. Global Tuberculosis Drugs Sales by Type (Kilotons)
Table 23. Global Tuberculosis Drugs Market Size by Type (M USD)
Table 24. Global Tuberculosis Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tuberculosis Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Tuberculosis Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Tuberculosis Drugs Market Size Share by Type (2019-2024)
Table 28. Global Tuberculosis Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tuberculosis Drugs Sales (Kilotons) by Application
Table 30. Global Tuberculosis Drugs Market Size by Application
Table 31. Global Tuberculosis Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tuberculosis Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Tuberculosis Drugs Market Share by Application (2019-2024)
Table 35. Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tuberculosis Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Tuberculosis Drugs Basic Information
Table 44. Pfizer Inc Tuberculosis Drugs Product Overview
Table 45. Pfizer Inc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Tuberculosis Drugs SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Lupin Laboratories Ltd Tuberculosis Drugs Basic Information
Table 50. Lupin Laboratories Ltd Tuberculosis Drugs Product Overview
Table 51. Lupin Laboratories Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lupin Laboratories Ltd Business Overview
Table 53. Lupin Laboratories Ltd Tuberculosis Drugs SWOT Analysis
Table 54. Lupin Laboratories Ltd Recent Developments
Table 55. AstraZeneca Plc Tuberculosis Drugs Basic Information
Table 56. AstraZeneca Plc Tuberculosis Drugs Product Overview
Table 57. AstraZeneca Plc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Plc Tuberculosis Drugs SWOT Analysis
Table 59. AstraZeneca Plc Business Overview
Table 60. AstraZeneca Plc Recent Developments
Table 61. Cadila Pharmaceuticals Tuberculosis Drugs Basic Information
Table 62. Cadila Pharmaceuticals Tuberculosis Drugs Product Overview
Table 63. Cadila Pharmaceuticals Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cadila Pharmaceuticals Business Overview
Table 65. Cadila Pharmaceuticals Recent Developments
Table 66. Novartis AG Tuberculosis Drugs Basic Information
Table 67. Novartis AG Tuberculosis Drugs Product Overview
Table 68. Novartis AG Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. Alkem Laboratories Ltd Tuberculosis Drugs Basic Information
Table 72. Alkem Laboratories Ltd Tuberculosis Drugs Product Overview
Table 73. Alkem Laboratories Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Alkem Laboratories Ltd Business Overview
Table 75. Alkem Laboratories Ltd Recent Developments
Table 76. Cipla Ltd Tuberculosis Drugs Basic Information
Table 77. Cipla Ltd Tuberculosis Drugs Product Overview
Table 78. Cipla Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cipla Ltd Business Overview
Table 80. Cipla Ltd Recent Developments
Table 81. Otsuka Pharmaceutical Tuberculosis Drugs Basic Information
Table 82. Otsuka Pharmaceutical Tuberculosis Drugs Product Overview
Table 83. Otsuka Pharmaceutical Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Otsuka Pharmaceutical Business Overview
Table 85. Otsuka Pharmaceutical Recent Developments
Table 86. Sanofi Tuberculosis Drugs Basic Information
Table 87. Sanofi Tuberculosis Drugs Product Overview
Table 88. Sanofi Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Business Overview
Table 90. Sanofi Recent Developments
Table 91. Abbott Tuberculosis Drugs Basic Information
Table 92. Abbott Tuberculosis Drugs Product Overview
Table 93. Abbott Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. ANI Pharmaceuticals, Inc Tuberculosis Drugs Basic Information
Table 97. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Overview
Table 98. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ANI Pharmaceuticals, Inc Business Overview
Table 100. ANI Pharmaceuticals, Inc Recent Developments
Table 101. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Basic Information
Table 102. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Overview
Table 103. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Teva Pharmaceutical Industries Ltd Business Overview
Table 105. Teva Pharmaceutical Industries Ltd Recent Developments
Table 106. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Basic Information
Table 107. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Overview
Table 108. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Macleods Pharmaceuticals Ltd. Business Overview
Table 110. Macleods Pharmaceuticals Ltd. Recent Developments
Table 111. Johnson and Johnson Tuberculosis Drugs Basic Information
Table 112. Johnson and Johnson Tuberculosis Drugs Product Overview
Table 113. Johnson and Johnson Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Recent Developments
Table 116. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Basic Information
Table 117. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Overview
Table 118. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Business Overview
Table 120. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Recent Developments
Table 121. Eli Lilly and Company Tuberculosis Drugs Basic Information
Table 122. Eli Lilly and Company Tuberculosis Drugs Product Overview
Table 123. Eli Lilly and Company Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Eli Lilly and Company Business Overview
Table 125. Eli Lilly and Company Recent Developments
Table 126. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Basic Information
Table 127. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Overview
Table 128. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Viatris Inc. (Mylan N.V.) Business Overview
Table 130. Viatris Inc. (Mylan N.V.) Recent Developments
Table 131. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Basic Information
Table 132. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Overview
Table 133. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Sun Pharmaceutical Industries Ltd. Business Overview
Table 135. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 136. Global Tuberculosis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Tuberculosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Tuberculosis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Tuberculosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Tuberculosis Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Tuberculosis Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Tuberculosis Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Tuberculosis Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Tuberculosis Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Tuberculosis Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Drugs Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tuberculosis Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2022)
Table 10. Global Market Tuberculosis Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tuberculosis Drugs Sales Sites and Area Served
Table 12. Manufacturers Tuberculosis Drugs Product Type
Table 13. Global Tuberculosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tuberculosis Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Drugs Market Challenges
Table 22. Global Tuberculosis Drugs Sales by Type (Kilotons)
Table 23. Global Tuberculosis Drugs Market Size by Type (M USD)
Table 24. Global Tuberculosis Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tuberculosis Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Tuberculosis Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Tuberculosis Drugs Market Size Share by Type (2019-2024)
Table 28. Global Tuberculosis Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tuberculosis Drugs Sales (Kilotons) by Application
Table 30. Global Tuberculosis Drugs Market Size by Application
Table 31. Global Tuberculosis Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tuberculosis Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Tuberculosis Drugs Market Share by Application (2019-2024)
Table 35. Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tuberculosis Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tuberculosis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tuberculosis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Tuberculosis Drugs Basic Information
Table 44. Pfizer Inc Tuberculosis Drugs Product Overview
Table 45. Pfizer Inc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Tuberculosis Drugs SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Lupin Laboratories Ltd Tuberculosis Drugs Basic Information
Table 50. Lupin Laboratories Ltd Tuberculosis Drugs Product Overview
Table 51. Lupin Laboratories Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lupin Laboratories Ltd Business Overview
Table 53. Lupin Laboratories Ltd Tuberculosis Drugs SWOT Analysis
Table 54. Lupin Laboratories Ltd Recent Developments
Table 55. AstraZeneca Plc Tuberculosis Drugs Basic Information
Table 56. AstraZeneca Plc Tuberculosis Drugs Product Overview
Table 57. AstraZeneca Plc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Plc Tuberculosis Drugs SWOT Analysis
Table 59. AstraZeneca Plc Business Overview
Table 60. AstraZeneca Plc Recent Developments
Table 61. Cadila Pharmaceuticals Tuberculosis Drugs Basic Information
Table 62. Cadila Pharmaceuticals Tuberculosis Drugs Product Overview
Table 63. Cadila Pharmaceuticals Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cadila Pharmaceuticals Business Overview
Table 65. Cadila Pharmaceuticals Recent Developments
Table 66. Novartis AG Tuberculosis Drugs Basic Information
Table 67. Novartis AG Tuberculosis Drugs Product Overview
Table 68. Novartis AG Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. Alkem Laboratories Ltd Tuberculosis Drugs Basic Information
Table 72. Alkem Laboratories Ltd Tuberculosis Drugs Product Overview
Table 73. Alkem Laboratories Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Alkem Laboratories Ltd Business Overview
Table 75. Alkem Laboratories Ltd Recent Developments
Table 76. Cipla Ltd Tuberculosis Drugs Basic Information
Table 77. Cipla Ltd Tuberculosis Drugs Product Overview
Table 78. Cipla Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cipla Ltd Business Overview
Table 80. Cipla Ltd Recent Developments
Table 81. Otsuka Pharmaceutical Tuberculosis Drugs Basic Information
Table 82. Otsuka Pharmaceutical Tuberculosis Drugs Product Overview
Table 83. Otsuka Pharmaceutical Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Otsuka Pharmaceutical Business Overview
Table 85. Otsuka Pharmaceutical Recent Developments
Table 86. Sanofi Tuberculosis Drugs Basic Information
Table 87. Sanofi Tuberculosis Drugs Product Overview
Table 88. Sanofi Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Business Overview
Table 90. Sanofi Recent Developments
Table 91. Abbott Tuberculosis Drugs Basic Information
Table 92. Abbott Tuberculosis Drugs Product Overview
Table 93. Abbott Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. ANI Pharmaceuticals, Inc Tuberculosis Drugs Basic Information
Table 97. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Overview
Table 98. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ANI Pharmaceuticals, Inc Business Overview
Table 100. ANI Pharmaceuticals, Inc Recent Developments
Table 101. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Basic Information
Table 102. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Overview
Table 103. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Teva Pharmaceutical Industries Ltd Business Overview
Table 105. Teva Pharmaceutical Industries Ltd Recent Developments
Table 106. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Basic Information
Table 107. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Overview
Table 108. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Macleods Pharmaceuticals Ltd. Business Overview
Table 110. Macleods Pharmaceuticals Ltd. Recent Developments
Table 111. Johnson and Johnson Tuberculosis Drugs Basic Information
Table 112. Johnson and Johnson Tuberculosis Drugs Product Overview
Table 113. Johnson and Johnson Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Recent Developments
Table 116. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Basic Information
Table 117. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Overview
Table 118. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Business Overview
Table 120. FRESENIUS SE and Co. KGaA (Fresenius Kabi) Recent Developments
Table 121. Eli Lilly and Company Tuberculosis Drugs Basic Information
Table 122. Eli Lilly and Company Tuberculosis Drugs Product Overview
Table 123. Eli Lilly and Company Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Eli Lilly and Company Business Overview
Table 125. Eli Lilly and Company Recent Developments
Table 126. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Basic Information
Table 127. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Overview
Table 128. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Viatris Inc. (Mylan N.V.) Business Overview
Table 130. Viatris Inc. (Mylan N.V.) Recent Developments
Table 131. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Basic Information
Table 132. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Overview
Table 133. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Sun Pharmaceutical Industries Ltd. Business Overview
Table 135. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 136. Global Tuberculosis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Tuberculosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Tuberculosis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Tuberculosis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Tuberculosis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Tuberculosis Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Tuberculosis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Tuberculosis Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Tuberculosis Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Tuberculosis Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Tuberculosis Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Tuberculosis Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tuberculosis Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Drugs Market Size (M USD), 2019-2030
Figure 5. Global Tuberculosis Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Tuberculosis Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Drugs Market Size by Country (M USD)
Figure 11. Tuberculosis Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Tuberculosis Drugs Revenue Share by Manufacturers in 2023
Figure 13. Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tuberculosis Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tuberculosis Drugs Market Share by Type
Figure 18. Sales Market Share of Tuberculosis Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Tuberculosis Drugs by Type in 2023
Figure 20. Market Size Share of Tuberculosis Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Tuberculosis Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tuberculosis Drugs Market Share by Application
Figure 24. Global Tuberculosis Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Tuberculosis Drugs Sales Market Share by Application in 2023
Figure 26. Global Tuberculosis Drugs Market Share by Application (2019-2024)
Figure 27. Global Tuberculosis Drugs Market Share by Application in 2023
Figure 28. Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tuberculosis Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tuberculosis Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tuberculosis Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 37. Germany Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tuberculosis Drugs Sales Market Share by Region in 2023
Figure 44. China Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tuberculosis Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tuberculosis Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tuberculosis Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tuberculosis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tuberculosis Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Tuberculosis Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Tuberculosis Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Tuberculosis Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Drugs Market Size (M USD), 2019-2030
Figure 5. Global Tuberculosis Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Tuberculosis Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Drugs Market Size by Country (M USD)
Figure 11. Tuberculosis Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Tuberculosis Drugs Revenue Share by Manufacturers in 2023
Figure 13. Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tuberculosis Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tuberculosis Drugs Market Share by Type
Figure 18. Sales Market Share of Tuberculosis Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Tuberculosis Drugs by Type in 2023
Figure 20. Market Size Share of Tuberculosis Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Tuberculosis Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tuberculosis Drugs Market Share by Application
Figure 24. Global Tuberculosis Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Tuberculosis Drugs Sales Market Share by Application in 2023
Figure 26. Global Tuberculosis Drugs Market Share by Application (2019-2024)
Figure 27. Global Tuberculosis Drugs Market Share by Application in 2023
Figure 28. Global Tuberculosis Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tuberculosis Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tuberculosis Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tuberculosis Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 37. Germany Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tuberculosis Drugs Sales Market Share by Region in 2023
Figure 44. China Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Tuberculosis Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tuberculosis Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tuberculosis Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tuberculosis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tuberculosis Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tuberculosis Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tuberculosis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tuberculosis Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Tuberculosis Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Tuberculosis Drugs Market Share Forecast by Application (2025-2030)
